Paclitaxel and Carboplatin for Recurrent or Persistent Cancer of the Cervix
暂无分享,去创建一个
H. Gallion | J. Kelley | R. Edwards | A. Kunschner | A. Sit | R. Edwards
[1] M. Piver,et al. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study. , 1999, Gynecologic oncology.
[2] D. Gershenson,et al. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Dimopoulos,et al. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] C. Levenback,et al. Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Winn,et al. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix , 1997, Anti-cancer drugs.
[6] W. Mcguire,et al. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] R. Vance,et al. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. , 1995, Seminars in oncology.
[8] Thompson Wm,et al. Imaging primary and metastatic cancer of the liver. , 1991 .
[9] D. Alberts,et al. Cisplatin in advanced cancer of the cervix: an update. , 1991, Seminars in oncology.
[10] D. Alberts,et al. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study. , 1990, Gynecologic oncology.
[11] P. Disaia,et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] P. Disaia,et al. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study. , 1989, Gynecologic oncology.
[13] P. Disaia,et al. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Mortel,et al. Treatment outcome of recurrent cervical cancer , 1983, Journal of surgical oncology.
[15] L. Lagasse,et al. Cis‐platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group , 1981, Cancer.
[16] R. Souhami,et al. A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix , 2004, Cancer Chemotherapy and Pharmacology.
[17] L. Roman,et al. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. , 2000, Gynecologic oncology.
[18] D. Mutch,et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.